World's Best Scientists 2026 revealed!

Anthony W. Ford-Hutchinson publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Anthony W. Ford-Hutchinson sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

The last bar groups every scientist with 1,295 publications or more.

Anthony W. Ford-Hutchinson D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Anthony W. Ford-Hutchinson sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

The last bar groups every scientist with 159 D-Index or more.

Overview

Anthony W. Ford-Hutchinson is an independent scientist and consultant based in the United States. Their professional affiliation is categorized as an independent expert rather than being tied to a specific institution or organization.

There is no publicly available information regarding recent publications, coauthors, or a record of frequent venues in which they have published. Likewise, no specific book publications or awards have been recorded for this scientist.

Details about their main fields and subfields of study, as well as specific topics of research, have not been documented or provided in accessible records.

Given the available data, Anthony W. Ford-Hutchinson's profile reflects an individual engaged in scientific research and consulting independently within the United States. Without further detailed records, additional insights into the scope or impact of their work cannot be determined.

Best Publications

  • Identification and isolation of a membrane protein necessary for leukotriene production

    Douglas K. Miller;John W. Gillard;Philip J. Vickers;Sharon Sadowski

  • Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

    D Riendeau;M D Percival;C Brideau;S Charleson

  • The Role of Arachidonic Acid Oxygenation Products in Pain and Inflammation

    Philip Davies;Philip J. Bailey;Marvin M. Goldenberg;Anthony W. Ford-Hutchinson

  • The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

    P Prasit;Z Wang;C Brideau;C.-C Chan

  • Rofecoxib [Vioxx, MK-0966; 4-(4′-Methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles

    Chan Cc;Boyce S;Brideau C;Charleson S

  • Common structural features of MAPEG -- a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism.

    Per-Johan Jakobsson;Ralf Morgenstern;Joseph Mancini;Anthony Ford-Hutchinson

  • Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.

    D Riendeau;M D Percival;S Boyce;C Brideau

  • L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor

    J Gillard;A W Ford-Hutchinson;C Chan;S Charleson

  • Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach.

    C C Chan;S Boyce;C Brideau;A W Ford-Hutchinson

  • MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes.

    C A Rouzer;A W Ford-Hutchinson;H E Morton;J W Gillard

  • Pharmacology of L-660,711 (MK-571): a novel potent and selective leukotriene D4 receptor antagonist.

    T. R. Jones;R. Zamboni;M. Belley;E. Champion

  • Pharmacology of montelukast sodium (Singulair™), a potent and selective leukotriene D4 receptor antagonist

    T R Jones;M Labelle;M Belley;E Champion

  • Identification and Characterization of a Novel Human Microsomal Glutathione S-Transferase with Leukotriene C4 Synthase Activity and Significant Sequence Identity to 5-Lipoxygenase-activating Protein and Leukotriene C4 Synthase

    Per-Johan Jakobsson;Joseph A. Mancini;Anthony W. Ford-Hutchinson

  • Membrane-associated proteins in eicosanoid and glutathione metabolism (MAPEG). A widespread protein superfamily.

    Per-Johan Jakobsson;Ralf Morgenstern;Joseph Mancini;Anthony Ford-Hutchinson

  • Identification and characterization of a novel microsomal enzyme with glutathione-dependent transferase and peroxidase activities.

    Per-Johan Jakobsson;Joseph A. Mancini;Denis Riendeau;Anthony W. Ford-Hutchinson

  • Leukotriene A3. A poor substrate but a potent inhibitor of rat and human neutrophil leukotriene A4 hydrolase.

    J F Evans;D J Nathaniel;R J Zamboni;A W Ford-Hutchinson

  • Purification to homogeneity and the N-terminal sequence of human leukotriene C4 synthase: a homodimeric glutathione S-transferase composed of 18-kDa subunits.

    Donald W. Nicholson;Ambereen Ali;John P. Vaillancourt;Jimmy R. Calaycay

  • Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor.

    Christine Brideau;Chi-Chung Chan;S. Charleson;Deschenes Denis

  • Discovery of MK-0476, a potent and orally active leukotriene D4 receptor antagonist devoid of peroxisomal enxyme induction

    M. Labelle;M. Belley;Y. Gareau;J.Y. Gauthier

  • FLAP : A NOVEL DRUG TARGET FOR INHIBITING THE SYNTHESIS OF LEUKOTRIENES

    Anthony W. Ford-Hutchinson

Frequent Co-Authors

Robert Zamboni
Robert Zamboni MSD (United States)
Robert N. Young
Robert N. Young Simon Fraser University
Joseph A. Mancini
Joseph A. Mancini MSD (United States)
Donald W. Nicholson
Donald W. Nicholson MSD (United States)
Joshua Rokach
Joshua Rokach Florida Institute of Technology
Denis Riendeau
Denis Riendeau MSD (United States)
Brian P. Kennedy
Brian P. Kennedy MSD (United States)
Ralf Morgenstern
Ralf Morgenstern Karolinska Institute
Bengt Samuelsson
Bengt Samuelsson Karolinska Institute
Hans Bisgaard
Hans Bisgaard University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a Chemistry degree in the USA opens doors to various related career paths and educational opportunities. For those interested in law enforcement or legal services, understanding the best online associates in criminal justice can provide foundational skills that complement chemical expertise, especially in forensic science.

Alternatively, a Chemistry background can be valuable in legal support roles. Exploring the different types of paralegals is a viable path for science graduates keen on combining legal knowledge with scientific detail. Comprehensive insights into types of paralegals highlight career versatility and relevant salary expectations in this field.

In the pharmaceutical industry, Chemistry graduates often consider roles such as pharmaceutical sales representatives. Understanding the pharmaceutical rep salary and career paths is essential for planning long-term opportunities in this dynamic sector.

For those focusing on healthcare and medication, becoming a pharmacist is a natural ambition. It's important to know how long does it take to become a pharmacist to align academic goals with professional timelines.

Best Scientists Citing Anthony W. Ford-Hutchinson

Recently Published Articles